Your browser doesn't support javascript.
loading
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer.
Dagogo-Jack, Ibiayi; Yoda, Satoshi; Lennerz, Jochen K; Langenbucher, Adam; Lin, Jessica J; Rooney, Marguerite M; Prutisto-Chang, Kylie; Oh, Audris; Adams, Nathaniel A; Yeap, Beow Y; Chin, Emily; Do, Andrew; Marble, Hetal D; Stevens, Sara E; Digumarthy, Subba R; Saxena, Ashish; Nagy, Rebecca J; Benes, Cyril H; Azzoli, Christopher G; Lawrence, Michael S; Gainor, Justin F; Shaw, Alice T; Hata, Aaron N.
Afiliación
  • Dagogo-Jack I; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Yoda S; Harvard Medical School, Boston, Massachusetts.
  • Lennerz JK; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Langenbucher A; Harvard Medical School, Boston, Massachusetts.
  • Lin JJ; Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, Massachusetts.
  • Rooney MM; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Prutisto-Chang K; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Oh A; Harvard Medical School, Boston, Massachusetts.
  • Adams NA; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Yeap BY; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Chin E; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Do A; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Marble HD; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Stevens SE; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Digumarthy SR; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Saxena A; Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, Massachusetts.
  • Nagy RJ; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Benes CH; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
  • Azzoli CG; Department of Medicine, Weill Cornell Medicine, New York, New York.
  • Lawrence MS; Guardant Health, Inc., Redwood City, California.
  • Gainor JF; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Shaw AT; Harvard Medical School, Boston, Massachusetts.
  • Hata AN; Massachusetts General Hospital Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Clin Cancer Res ; 26(11): 2535-2545, 2020 06 01.
Article en En | MEDLINE | ID: mdl-32086345
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amplificación de Genes / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Inhibidores de Proteínas Quinasas / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amplificación de Genes / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Inhibidores de Proteínas Quinasas / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos